News Digest / Lukas Schmidt

Author: Lukas Schmidt

03:53am, Friday, Mar 27, 2026

Novartis Sets Sights on Excellergy with $2 Billion Acquisition Deal

Novartis is planning to acquire U.S. biotech firm Excellergy for up to $2 billion, boosting its immunology portfolio with a focus on food allergy treatments. The deal complements recent acquisitions, marking a robust biotech expansion strategy.

03:40am, Friday, Mar 27, 2026

Oxford BioMedica Holds Steady on 2026 Revenue and EBITDA Forecasts Amid US Expansion

04:43am, Thursday, Mar 26, 2026

Porsche SE Flags Earnings Hit Amid VW and Porsche AG Challenges in 2025

04:38am, Thursday, Mar 26, 2026

Ecora Royalties Surpasses Earnings Expectations, Prolongs Voisey's Bay Mine Life to 2044

04:36am, Thursday, Mar 26, 2026

H&M Beats Q1 Operating Profit Expectations Amid Slight March Sales Uptick

04:35am, Thursday, Mar 26, 2026

Morgan Stanley Highlights Key Indian Power Stocks As Capacity Expansion Accelerates

04:32am, Thursday, Mar 26, 2026

Bitcoin Dips Below $70K as Iran Conflict and US Crypto Regulation Stir Market Unease

04:18am, Thursday, Mar 26, 2026

Micron Slips as Google's New AI Memory Algorithm Raises Eyebrows

03:55am, Thursday, Mar 26, 2026

Arm's Shares Surge Amid Hopes for a Nvidia-Style Growth Story

03:54am, Thursday, Mar 26, 2026

Wacker Neuson Shows EBIT Boost Despite Revenue Drop in 2025

07:51am, Wednesday, Mar 25, 2026

Maire Tecnimont Shares Jump 6% as Kepler Cheuvreux Calls Iran War Selloff Unwarranted

07:50am, Wednesday, Mar 25, 2026

Codere Explores $2.3 Billion Sale, Eyes Strategic Shift in Gambling Sector

07:49am, Wednesday, Mar 25, 2026

On Holding Shares Drop 5% as CEO Martin Hoffmann Announces Departure

07:48am, Wednesday, Mar 25, 2026

Cipher Digital Shares Jump on Landmark 15-Year Data Center Lease and $200M Credit Facility

07:47am, Wednesday, Mar 25, 2026

American Express Targets Small and Mid-Market Firms with New Business Credit Cards